Ligand Pharmaceuticals
LGND
$70.46
Share price
-0.16%
Change (1 day)
-8.16%
Change (1 year)
Number of shares outstanding for Ligand Pharmaceuticals (LGND)
Number of shares outstanding as of April 2024 : 17,380,000
According to Ligand Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 17,380,000. At the end of 2023 the company had 17,380,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for Ligand Pharmaceuticals from 2022 to 2023
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2023 | 17.38 M | 2.9% |
| 2022 | 16.89 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,407,200,000 | 13,750.40% | 🇺🇸 USA |
 Pfizer PFE | 5,647,000,000 | 32,391.37% | 🇺🇸 USA |
 Eli Lilly LLY | 949,379,000 | 5,362.48% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | 2,978.25% | 🇺🇸 USA |
 Baxter BAX | 507,000,000 | 2,817.15% | 🇺🇸 USA |
 Merck MRK | 2,554,166,667 | 14,596.01% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,023,000,000 | 11,539.82% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,028,000,000 | 11,568.58% | 🇬🇧 UK |
 Spectrum Pharmaceuticals
SPPI | 201,918,066 | 1,061.78% | 🇺🇸 USA |